| Product Code: ETC328707 | Publication Date: Aug 2022 | Updated Date: Mar 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Singapore hydroxychloroquine and chloroquine market, imports experienced a 21.71% growth rate from 2023 to 2024. However, the compound annual growth rate (CAGR) for the period 2020-2024 was -17.53%. This decline can be attributed to shifting demand dynamics and regulatory changes impacting the market stability.

The hydroxychloroquine and chloroquine market in Singapore has experienced fluctuations in recent years, driven by global events such as the COVID-19 pandemic. These medications, originally used to treat malaria and certain autoimmune disorders, gained attention as potential treatments for COVID-19. However, their effectiveness and safety have been subjects of debate. The market saw increased demand during the early stages of the pandemic but has since stabilized. It remains an important component of Singapore pharmaceutical industry, catering to both domestic and international needs.
The Singapore Hydroxychloroquine and Chloroquine market have experienced fluctuations driven by factors related to the COVID-19 pandemic. Initially, there was heightened demand for these drugs for potential treatment, which drove market growth. Subsequently, their use became more regulated due to safety concerns. However, these drugs continue to be used for their established indications such as malaria and autoimmune diseases, which provides a stable base demand. Moreover, research into their potential applications in other medical conditions is contributing to market dynamics.
The hydroxychloroquine and chloroquine market in Singapore has faced significant challenges, particularly due to the controversy surrounding their use in the treatment of COVID-19. Safety concerns, including potential cardiac side effects, have raised doubts about the drugs` efficacy and safety. The market has also struggled with fluctuations in demand, leading to supply chain disruptions and shortages. Regulatory agencies have imposed stricter controls on these medications, further impacting their availability.
The use of hydroxychloroquine and chloroquine as potential treatments for COVID-19 garnered significant attention early in the pandemic. This led to increased demand for these drugs and disruptions in supply chains. However, as further research cast doubt on their effectiveness in treating the virus, demand decreased, and regulatory authorities in Singapore and globally imposed restrictions on their use. This market saw fluctuations tied to evolving COVID-19 treatment guidelines.
The Singapore hydroxychloroquine and chloroquine market involves pharmaceutical companies like Novartis, Sanofi, and Mylan. These companies are involved in the production and distribution of hydroxychloroquine and chloroquine-based medications used for treating malaria and autoimmune diseases. Their commitment to quality and safety standards makes them prominent contributors to public health in Singapore.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Hydroxychloroquine And Chloroquine Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, 2022 & 2032F |
3.3 Singapore Hydroxychloroquine And Chloroquine Market - Industry Life Cycle |
3.4 Singapore Hydroxychloroquine And Chloroquine Market - Porter's Five Forces |
3.5 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume Share, By Dosage, 2022 & 2032F |
3.6 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Singapore Hydroxychloroquine And Chloroquine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increased prevalence of diseases such as malaria and lupus requiring hydroxychloroquine and chloroquine treatment |
4.2.2 Growing awareness and acceptance of hydroxychloroquine and chloroquine for off-label use in treating conditions like rheumatoid arthritis and COVID-19 |
4.3 Market Restraints |
4.3.1 Regulatory restrictions or warnings on the use of hydroxychloroquine and chloroquine for certain conditions |
4.3.2 Concerns over potential side effects and risks associated with the use of hydroxychloroquine and chloroquine |
5 Singapore Hydroxychloroquine And Chloroquine Market Trends |
6 Singapore Hydroxychloroquine And Chloroquine Market, By Types |
6.1 Singapore Hydroxychloroquine And Chloroquine Market, By Dosage |
6.1.1 Overview and Analysis |
6.1.2 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Dosage, 2022-2032F |
6.1.3 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By 100 mg, 2022-2032F |
6.1.4 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By 200 mg, 2022-2032F |
6.1.5 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By 250 mg, 2022-2032F |
6.1.6 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By 500 mg, 2022-2032F |
6.2 Singapore Hydroxychloroquine And Chloroquine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By COVID-19, 2022-2032F |
6.2.3 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Rheumatoid Arthritis, 2022-2032F |
6.2.4 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Malaria, 2022-2032F |
6.2.5 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Others, 2022-2032F |
6.3 Singapore Hydroxychloroquine And Chloroquine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Hospital Pharmacies, 2022-2032F |
6.3.3 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Retail Pharmacies, 2022-2032F |
6.3.4 Singapore Hydroxychloroquine And Chloroquine Market Revenues & Volume, By Online Pharmacies, 2022-2032F |
7 Singapore Hydroxychloroquine And Chloroquine Market Import-Export Trade Statistics |
7.1 Singapore Hydroxychloroquine And Chloroquine Market Export to Major Countries |
7.2 Singapore Hydroxychloroquine And Chloroquine Market Imports from Major Countries |
8 Singapore Hydroxychloroquine And Chloroquine Market Key Performance Indicators |
8.1 Number of prescriptions for hydroxychloroquine and chloroquine |
8.2 Patient adherence rates to hydroxychloroquine and chloroquine treatment regimens |
8.3 Number of clinical trials evaluating the efficacy of hydroxychloroquine and chloroquine for various conditions |
9 Singapore Hydroxychloroquine And Chloroquine Market - Opportunity Assessment |
9.1 Singapore Hydroxychloroquine And Chloroquine Market Opportunity Assessment, By Dosage, 2022 & 2032F |
9.2 Singapore Hydroxychloroquine And Chloroquine Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Singapore Hydroxychloroquine And Chloroquine Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Singapore Hydroxychloroquine And Chloroquine Market - Competitive Landscape |
10.1 Singapore Hydroxychloroquine And Chloroquine Market Revenue Share, By Companies, 2025 |
10.2 Singapore Hydroxychloroquine And Chloroquine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here